The global oncology blood testing industry is poised for extraordinary expansion, projected to soar from a value of US$ 3,851.7 Million in 2022 to an estimated US$ 18,278.2 Million by 2032. Anticipated to showcase remarkable growth at a robust CAGR of 15.2% throughout the forecast period, this market surge highlights a substantial shift and advancement …